Key takeaways
- Many peptides are messengers: hormones such as oxytocin and GLP-1 carry a signal from the cells that make them to the cells that respond.
- Peptide hormones are water-soluble, so they act on receptors at the cell surface, and only cells with the matching receptor respond.
- Enzymes, the kidneys, and the liver clear them fast: oxytocin’s plasma half-life is about 1 to 6 minutes, natural GLP-1’s about 2.
- Digestion exists to break peptide bonds, which is why most peptide medicines are not given by mouth; the label for one oral semaglutide tablet, Rybelsus, puts the share reaching the blood at 0.4% to 1%.
- A mechanism is not a result: a molecule binding a receptor in a dish does not show what it does in a person.
01What do peptides do in the body?
Many of the peptides the body makes share one job: they carry messages. What a given peptide does depends on which one it is, because “peptide” names a kind of molecule, not a job. The definition itself is on what are peptides.
A gland or a cell releases the peptide, it travels, and it changes what another cell is doing. Peptides that travel in the blood this way are called peptide hormones.
Three examples show the pattern. Oxytocin is released from the posterior pituitary gland and stimulates contractions of the uterus during childbirth. Insulin, made in the pancreas, lowers blood glucose. GLP-1, a hormone of 30 amino acids made by cells in the lining of the gut, is released after a meal.
Insulin sits on the line between peptide and protein, and some textbooks file it with the proteins (why the line is blurry). It is included here because it delivers its message the same way.
02How do peptides work as messengers?
A trigger prompts a cell to release the peptide. GLP-1, for example, is released in response to a meal.
The blood carries a hormone almost everywhere, but it affects only its target cells: the ones with a matching receptor.
Water-soluble hormones cannot pass through the fatty membrane around a cell, so they bind a receptor on its outer surface. Each receptor recognises a specific shape. Oxytocin acts on the muscle of the uterus because that muscle carries specific oxytocin receptors.
Binding starts a chain of events inside the cell. Many hormone receptors pass the signal through a G protein to a second messenger, most often a small molecule called cyclic AMP.
The cell changes what it is doing. Insulin’s signal makes muscle and fat absorb more glucose and the liver make less of it. GLP-1’s main actions are to increase insulin release and reduce glucagon release.
Steroid hormones work differently. They are built from lipids, cross the cell membrane, and bind receptors inside the cell. It is one of the clearest differences between the two families, covered on are peptides steroids.
03Three hormones, side by side
Each of these hormones has an approved medicine built on it. The uses below come from the official US labels.
| Hormone | Made in | The message | Approved medicine and labelled use | How fast it is cleared |
|---|---|---|---|---|
| Oxytocin | Posterior pituitary | Contractions of the uterus during childbirth | Pitocin (oxytocin): starting or improving uterine contractions, for specific medical reasons | Plasma half-life about 1 to 6 minutes; removed mainly by the kidney and liver |
| Insulin | Pancreas | Lowers blood glucose | Humulin R (insulin human): improving glycemic control in adults and children with diabetes | Cleared mainly by the liver |
| GLP-1 | Cells in the gut lining | Released after meals; raises insulin release and lowers glucagon release | Natural GLP-1 lasts too briefly for routine treatment. Semaglutide (Ozempic), a modified GLP-1, is a prescription medicine approved to improve blood-sugar control in adults with type 2 diabetes, among other labelled uses | Natural GLP-1: about 2 minutes. Semaglutide: about 1 week |
Labelled uses are summarised from US prescribing information. Not medical advice.
04Why do peptide hormones break down so fast?
Enzymes called proteases cut peptide bonds, and the kidneys and liver clear what is left. A hormone’s half-life is the time it takes for half of it to be broken down. For the peptide hormones on this page, it is short.
GLP-1 is the extreme case. An enzyme called DPP-4 inactivates it so fast that the process starts before the hormone has even left the gut, and its elimination half-life is about 2 minutes. Oxytocin’s plasma half-life is about 1 to 6 minutes.
A short life is part of how signalling works: the message stops soon after the cell stops sending it. It is also a problem for medicine. Natural GLP-1 lasts too briefly for routine treatment, so drug makers changed the molecule. Semaglutide’s label credits two changes: binding to albumin in the blood, which slows its removal by the kidneys, and resistance to DPP-4. Its half-life is about a week. How changes like these are built into a peptide is on types of peptides.
05Why can’t most peptides survive the gut?
Digestion is built to break peptide bonds. In the stomach, acid and the enzyme pepsin cut proteins into smaller chains. In the small intestine, pancreatic enzymes such as trypsin and chymotrypsin keep cutting, and enzymes on the gut lining finish the job. Almost all protein, 95 to 98 percent, is digested and absorbed in the small intestine.
What crosses the gut wall is mostly single amino acids, plus some pieces two or three amino acids long, and most of those are split into amino acids inside the cells of the gut lining. A peptide hormone swallowed as a pill meets the same enzymes, and the structure of the gut wall is a second barrier.
That is why insulin and most other peptide medicines are not given by mouth. Humulin R’s label, for example, is for use under the skin or into a vein. A 2020 review in Nature Reviews Drug Discovery describes the barriers to oral delivery as substantial and lists the workarounds being developed: permeation enhancers, inhibitors of gut enzymes, and mucus- and cell-penetrating peptides.
The best-known success shows the size of the problem. Oral semaglutide (Rybelsus) is a tablet that includes an absorption enhancer called SNAC. Even with that help, its label puts absolute bioavailability, the share that reaches the bloodstream, at 0.4% to 1%. Some small food-derived fragments do get absorbed, a different story told on collagen vs research peptides.
06What this means when you read about a peptide
- Ask which receptor, in which tissue. A peptide acts only where its receptor is.
- Ask how the molecule reached its target. The route, the half-life, and the enzymes along the way decide whether it arrives intact.
- Don’t read a mechanism as a result. A molecule binding a receptor in a dish, or acting in an animal, does not show what it does in a person.
- Don’t carry evidence across names or routes. A finding for one peptide, given one way, says nothing on its own about another.
How the evidence differs between approved medicines, cosmetic peptides, and research compounds is on what are peptides used for.
07What we don’t know
Even for well-studied hormones, the picture has gaps.
How much of natural GLP-1’s effect travels through the blood. Because it is broken down so fast, a 2007 review raised the possibility that some of its actions are carried by nerves in the gut and liver that have GLP-1 receptors.
Why some approved medicines work as they do. Ozempic’s label states that the mechanism of its kidney-related risk reduction “has not been established”.
Whether a mechanism seen in cells or animals carries over to people. That has to be tested in people, peptide by peptide.
Educational content. Not medical advice.